Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the pot...
Main Authors: | Sara E. Bodbin, Chris Denning, Diogo Mosqueira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Methods and Protocols |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-9279/3/3/57 |
Similar Items
-
Sarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
by: Qianliang Yuan, et al.
Published: (2022-01-01) -
The challenging nature of primary T lymphocytes for transfection: Effect of protamine sulfate on the transfection efficiency of chemical transfection reagents
by: Ilnaz Rahimmanesh, et al.
Published: (2020-01-01) -
Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides
by: Tao Wang, et al.
Published: (2018-10-01) -
Lipid-based Transfection Reagents Exhibit Cryo-induced Increase in Transfection Efficiency
by: Helena Sork, et al.
Published: (2016-01-01) -
Liposome-mediated transfection /
by: 347843 Whitt, Michael, et al.